(May 9, 2018, 12:53 PM EDT) -- BOSTON — The Massachusetts federal judge overseeing the New England Compounding Center (NECC) criminal case on May 7 granted a motion by six of the nine remaining defendants to exclude evidence from their Oct. 4 trial about patient deaths and injuries from contaminated methylprednisolone acetate (MPA) made by the drug compounding pharmacy (United States v. Barry J. Cadden, et al., No. 14-10363, D. Mass., 2018 U.S. Dist. LEXIS 76613)....